Methyl 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 25g

7-Amino-4-bromoisoindolin-1-one, 96%, 250mg

4-Trimethylsilyl-3-butyn-2-ol>97.0%(GC)5g

2-cyclopropyl-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid, 95%, 5g

4-(3-Bromo-4-fluorophenyl)-3-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one, 98%, 250mg

5-Acetyl-2-(2-ethoxyphenoxy) pyridine, 95%, 250mg

2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride, 95.0%, 25g

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide, 95%, 100mg

Diphenyl(4-vinylphenyl)phosphane, 98+%, 1g

Bromopentafluorobenzene, 99.0%, 50g

3-Ethyl-5-methylphenol, 95.0%, 250mg

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 150, 250 ml, 120 mm, 1 Piece

(R)-tert-Leucinol, 95.0%, 5g